Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Arg-Gly-Asp | Arg-Gly-Asp. Group: Biochemicals. Alternative Names: Arginyl-Glycyl-Aspartic acid. Grades: Highly Purified. CAS No. 99896-85-2. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C12H22N6O6. US Biological Life Sciences. |  Worldwide |
| Arg-Gly-Asp | RGD (Arg-Gly-Asp) Peptides is a cell adhesion motif which can mimic cell adhesion proteins and bind to integrins. Synonyms: Arginyl-Glycyl-Aspartic acid; RGD peptide. Grades: Min 98%. CAS No. 99896-85-2. Molecular formula: C12H22N6O6. Mole weight: 346.34. |  |
| Arg-Gly-Asp-Cys acetate | Arg-Gly-Asp-Cys, a fibronectin binding motif to cell adhesion molecules, inhibits platelet aggregation and fibrinogen binding. Synonyms: L-arginyl-glycyl-L-alpha-aspartyl-L-cysteine; RGDC peptide. Molecular formula: C17H31N7O9S. Mole weight: 509.54. | |
| Arg-Gly-Asp-Ser | ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| Arg-Gly-Asp-Ser | Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function. It is a tetrapeptide found on fibronectin, fibrinogen α, and von Willebrand factor, but not vitronectin or collagen. It decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9. It inhibits thrombin-induced binding of platelets to fibronectin, fibrinogen α, and von Willebrand factor. It promotes cell attachment and abrogates apoptosis via the mitochondrial pathway in osteoblasts in vitro. It also blocks the attachment of certain pathogens to cells. Uses: Platelet aggregation inhibitors. Synonyms: Arg Gly Asp Ser; RGDS peptide; Fibronectin Inhibitor. Grades: >98%. CAS No. 91037-65-9. Molecular formula: C15H27N7O8. Mole weight: 433.42. | |
| Arg-Gly-Asp-Ser acetate | Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function. It is a tetrapeptide found on fibronectin, fibrinogen α, and von Willebrand factor, but not vitronectin or collagen. It decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9. It inhibits thrombin-induced binding of platelets to fibronectin, fibrinogen α, and von Willebrand factor. It promotes cell attachment and abrogates apoptosis via the mitochondrial pathway in osteoblasts in vitro. It also blocks the attachment of certain pathogens to cells. Molecular formula: C17H31N7O10. Mole weight: 493.47. | |
| Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro | ?97% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Arg-Gly-Asp TFA salt | Arg-Gly-Asp can be used as a brain tumor targeting ligand. Synonyms: RGD (Trifluoroacetate); RGD Trifluoroacetate; HY-P0278A. Grades: ≥98%. CAS No. 2378808-45-6. Molecular formula: C14H23F3N6O8. Mole weight: 460.36. | |
| Cyclo(-Arg-Gly-Asp-D-Phe-Glu) | Cyclo(-Arg-Gly-Asp-D-Phe-Glu), a cyclic RGD peptide, has been used as an integrin ligand for radiologic labeling, on gold nanoparticles and for the delivery of nanomedicine. Its negative control c(RADfE) is also available. Synonyms: cyclo[L-arginyl-glycyl-L-alpha-aspartyl-D-phenylalanyl-L-alpha-glutamyl]; c(RGDfE); Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-α-glutamyl). Grades: ≥95%. CAS No. 756500-22-8. Molecular formula: C26H36N8O9. Mole weight: 604.62. | |
| Cyclo(-Arg-Gly-Asp-D-Phe-Val) | Cyclo(-Arg-Gly-Asp-D-Phe-Val) is a potent inhibitor of cell adhesion. It inhibited tumor cell adhesion to laminin and vitronectin substrates. Synonyms: c-[-Arg-Gly-Asp-fV-]; Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-valyl). CAS No. 137813-35-5. Molecular formula: C26H38N8O7. Mole weight: 574.63. | |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) | Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) can be used for the research of acute myeloid leukemia. Uses: Designed for use in research and industrial production. Product Category: Inhibitors. Appearance: Solid. CAS No. 137813-35-5. Molecular formula: C26H38N8O7. Mole weight: 574.63. Purity: 0.95. Product ID: ACM137813355-1. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) (Cyclo(RGDfV) (TFA))is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) can be used for the research of acute myeloid leukemia [1]. Uses: Scientific research. Group: Peptides. Alternative Names: Cyclo(RGDfV) TFA; C(RGDfV) TFA. CAS No. 199807-33-5. Pack Sizes: 5 mg. Product ID: HY-P1613A. |  |
| Cyclo(-Arg-Gly-Asp-D-Tyr-ε-azido-Nle) | Cyclo(-Arg-Gly-Asp-D-Tyr-ε-azido-Nle), an azido derivative of cRGDyK, can be modified or linked to carriers by click chemistry. Synonyms: Azido-c(RGDyK); Cyclo(L-arginylglycyl-L-α-aspartyl-D-tyrosyl-6-azido-L-norleucyl); cyclo[Arg-Gly-Asp-D-Tyr-Nle(N3)]. Grades: ≥95%. CAS No. 1392269-21-4. Molecular formula: C27H39N11O8. Mole weight: 645.68. | |
| Cyclo(-Arg-Gly-Asp-D-Tyr-Lys(Tide FluorTM 7WS)) | Cyclo(-Arg-Gly-Asp-D-Tyr-Lys(Tide FluorTM 7WS)) is a cyclic RGD peptide labeled with a fluorophore absorbing at 749 nm and emitting at 775 nm. Synonyms: c[RGDyK(Tide FluorTM 7WS)]. Grades: ≥90%. Molecular formula: C27H41N9O8 + dye. Mole weight: 1378. | |
| H-Glu[cyclo(-Arg-Gly-Asp-D-Phe-Lys)]-cyclo(-Arg-Gly-Asp-D-Phe-Lys) | H-Glu[cyclo(-Arg-Gly-Asp-D-Phe-Lys)]-cyclo(-Arg-Gly-Asp-D-Phe-Lys) is the dimeric form of c(RGDfK), which has better tumor-targeting properties than the monomer. It binds readily to dyes, drug molecules, or chelators. The 68Ga complex of DOTA-E(c(RGDfK))2 has been evaluated as a therapeutic radiopharmaceutical. Synonyms: Cyclo[D-Phe-N6-[N5-[3-[[cyclo(L-Ala-L-Arg-Gly-L-Asp-D-Phe-)]-3-yl]propyl]-L-Gln-]-L-Lys-L-Arg-Gly-L-Asp-]; E(c(RGDfK))2; SU 016. Grades: ≥95%. CAS No. 250612-47-6. Molecular formula: C59H87N19O16. Mole weight: 1318.44. | |
| Cilengitide | Cilengitide is a cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(V)beta(3) and alpha(V)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. It is being studied for the treatment of glioblastoma. Synonyms: 2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid. Grades: ≥98%. CAS No. 188968-51-6. Molecular formula: C27H40N8O7. Mole weight: 588.65. | |
| Cilengitide TFA salt | Cilengitide TFA salt, is a cyclic Arg-Gly-Asp acid pentapeptide that induces anoikis in angiogenic blood vessels and brain tumor, selectively and potently blocks the ligation of theαvβ3 andαvβ5 integrins to provisional matrix proteins such as vitronectin, fibronectin, fibrinogen, von Willebrand factor, osteopontin, and others. Synonyms: Cilengitide trifluoroacetate. Grades: >98%. CAS No. 199807-35-7. Molecular formula: C29H41F3N8O9. Mole weight: 702.68. | |
| Cyclo(RGDfC) acetate | Cyclo(RGDfC) acetate is a potent and selective inhibitor of the αvβ3 integrin receptor. Synonyms: Cyclo(-RGDfC) acetate; cyclo[Arg-Gly-Asp-D-Phe-Cys] acetate; cyclo[L-arginyl-glycyl-L-alpha-aspartyl-D-phenylalanyl-L-cysteinyl] acetic acid; Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-cysteinyl) acetate. Grades: ≥95%. CAS No. 2171504-31-5. Molecular formula: C26H38N8O9S. Mole weight: 638.69. | |
| Cyclo(RGDyK)-Cy5.5 | Synonyms: Cyclo(Arg-Gly-Asp-D-Tyr-Lys)-Cy5.5; c(RGDyK)-Cy5.5; Cyclo[L-arginylglycyl-L-α-aspartyl-D-tyrosyl-N6-[6-[2-[5-(3-ethyl-1,3-dihydro-1,1-dimethyl-6,8-disulfo-2H-benz[e]indol-2-ylidene)-1,3-pentadien-1-yl]-1,1-dimethyl-6,8-disulfo-1H-benz[e]indolio]-1-oxohexyl]-L-lysyl], inner salt; RGD-Cy 5.5. CAS No. 820967-21-3. Molecular formula: C68H83N11O21S4. Mole weight: 1518.71. | |
| Fibronectin CS1 Peptide | Fibronectin CS1 Peptide lacks a domain containing Arg-Gly-Asp, and it can effectively inhibit tumor metastasis in both spontaneous and experimental metastatic models. Synonyms: Fibronectin CS-1 Fragment (1978-1985); H-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr-OH; L-alpha-glutamyl-L-isoleucyl-L-leucyl-L-alpha-aspartyl-L-valyl-L-prolyl-L-seryl-L-threonine; (3S,6S,9S,12S,15S)-15-amino-12-sec-butyl-3-((S)-2-((S)-1-((1S,2R)-1-carboxy-2-hydroxypropylamino)-3-hydroxy-1-oxopropan-2-ylcarbamoyl)pyrrolidine-1-carbonyl)-6-(carboxymethyl)-9-isobutyl-2-methyl-5,8,11,14-tetraoxo-4,7,10,13-tetraazaoctadecan-18-oic acid. Grades: ≥95%. CAS No. 136466-51-8. Molecular formula: C38H64N8O15. Mole weight: 872.96. | |
| Fibronectin CS1 Peptide acetate | Fibronectin CS1 Peptide lacks a domain containing Arg-Gly-Asp, and it can effectively inhibit tumor metastasis in both spontaneous and experimental metastatic models. Synonyms: H-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr-OH.CH3CO2H; L-alpha-glutamyl-L-isoleucyl-L-leucyl-L-alpha-aspartyl-L-valyl-L-prolyl-L-seryl-L-threonine acetic acid. Grades: ≥95%. CAS No. 2760881-56-7. Molecular formula: C40H68N8O17. Mole weight: 933.01. | |
| Fluciclatide F-18 | Fluciclatide-F18 is a radiopharmaceutical compound of a small synthetic cyclic peptide containing an RGD-sequence (Arg-Gly-Asp) labeled with the positron-emitting isotope fluorine F 18 that may be used to selectively image tumor cells and tumor vasculature by PET imaging. The RGD motif of fluciclatide F 18 selectively binds to the alphaVbeta3 integrin receptor, commonly upregulated on the surfaces of tumor cells and endothelial cells of tumor vasculature. This agent may be of use in visualizing and quantifying the development of tumor vascularity in response to antiangiogenic agents. Synonyms: [18F]AH111585; 18F-Fluciclatide; Fluciclatide (f-18). CAS No. 879894-01-6. Molecular formula: C75H115FN18O27S3. Mole weight: 1815.02. | |
| iRGD peptide | iRGD peptide is a 9-amino acid peptide and a molecular mimicry agent. It homes and penetrates tumors, increasing accumulation and penetration of anticancer drugs into tumors. Synonyms: c(CRGDKGPDC); H-Cys(1)-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys(1)-OH; L-cysteinyl-L-arginyl-glycyl-L-alpha-aspartyl-L-lysyl-glycyl-L-prolyl-L-alpha-aspartyl-L-cysteine (1->9)-disulfide; Internalized-arginylglycylaspartic acid cyclic peptide; IRGD. Grades: 98%. CAS No. 1392278-76-0. Molecular formula: C35H57N13O14S2. Mole weight: 948.04. | |
| L-Valine,l-arginylglycyl-L-a-aspartyl- | L-Valine,l-arginylglycyl-L-a-aspartyl-. Uses: Designed for use in research and industrial production. Additional or Alternative Names: RGDV;ARG-GLY-ASP-VAL;H-ARG-GLY-ASP-VAL-OH;arginyl-glycyl-aspartyl-valine. Product Category: Heterocyclic Organic Compound. CAS No. 93674-99-8. Molecular formula: C17H31N7O7. Mole weight: 445.47. Product ID: ACM93674998. Alfa Chemistry ISO 9001:2015 Certified. | |
Our database is helping our users find suppliers everyday.
